Evidence map›Paper›PMID 34936035›Full record

ArticleCellular and molecular life sciences : CMLS2021

Identification of inflammatory markers in eosinophilic cells of the immune system: fluorescence, Raman and CARS imaging can recognize markers but differently.

Aleksandra Borek-Dorosz, Marek Grosicki, Jakub Dybas, Ewelina Matuszyk, Marko Rodewald, Tobias Meyer-Zedler, Michael Schmitt, Juergen Popp, Kamilla Malek, Malgorzata Baranska

Open access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Analytical Techniques for Single-Cell Biochemical Assays of Lipids.Annual review of biomedical engineering · 2023
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Aleksandra Borek-DoroszFaculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387, Krakow, Poland.ORCID http://orcid.org/0000-0003-3699-9453
Marek GrosickiJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, 30-348, Krakow, Poland.ORCID http://orcid.org/0000-0002-0122-719X
Jakub DybasJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, 30-348, Krakow, Poland.ORCID http://orcid.org/0000-0003-2202-5068
Ewelina MatuszykJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, 30-348, Krakow, Poland.ORCID http://orcid.org/0000-0002-4501-0937
Marko RodewaldInstitute of Physical Chemistry (IPC) and Abbe Center of Photonics (ACP), Friedrich-Schiller-University, Helmholtzweg 4, Jena, Germany.ORCID http://orcid.org/0000-0001-9021-8270
Tobias Meyer-ZedlerInstitute of Physical Chemistry (IPC) and Abbe Center of Photonics (ACP), Friedrich-Schiller-University, Helmholtzweg 4, Jena, Germany.ORCID http://orcid.org/0000-0001-6740-629X
Michael SchmittLeibniz Institute of Photonic Technology e.V., Member of Leibniz Health Technologies, Albert-Einstein-Str. 9, Jena, Germany.ORCID http://orcid.org/0000-0002-3807-3630
Juergen PoppInstitute of Physical Chemistry (IPC) and Abbe Center of Photonics (ACP), Friedrich-Schiller-University, Helmholtzweg 4, Jena, Germany.ORCID http://orcid.org/0000-0003-4257-593X
Kamilla MalekFaculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387, Krakow, Poland. kamilla.malek@uj.edu.pl.ORCID http://orcid.org/0000-0003-0582-2743
Malgorzata BaranskaFaculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387, Krakow, Poland. m.baranska@uj.edu.pl.ORCID http://orcid.org/0000-0001-8826-3144
Jagiellonian University · PLHelmholtz Institute Jena · DELeibniz Institute of Photonic Technology · DE

Funding

narodowe centrum nauki UMO-2016/22/M/ST4/00150
6 · The paper itself

Abstract

Eosinophils (Eos) play an important role in the immune system's response releasing several inflammatory factors and contributing to allergic rhinitis, asthma, or atopic dermatitis. Since Eos have a relatively short lifetime after isolation from blood, usually eosinophilic cell line (EoL-1) is used to study mechanisms of their activation and to test therapies. In particular, EoL-1 cells are examined in terms of signalling pathways of the inflammatory response manifested by the presence of lipid bodies (LBs). Here we examined the differences in response to inflammation modelled by various factors, between isolated human eosinophils and EoL-1 cells, as manifested in the number and chemical composition of LBs. The analysis was performed using fluorescence, Raman, and coherent anti-Stokes Raman scattering (CARS) microscopy, which recognised the inflammatory process in the cells, but it is manifested slightly differently depending on the method used. We showed that unstimulated EoL-1 cells, compared to isolated eosinophils, contained more LBs, displayed different nucleus morphology and did not have eosinophilic peroxidase (EPO). In EoL-1 cells stimulated with various proinflammatory agents, including butyric acid (BA), liposaccharide (LPS), or cytokines (IL-1β, TNF-α), an increased production of LBs with a various degree of lipid unsaturation was observed in spontaneous Raman spectra. Furthermore, stimulation of EoL-1 cells resulted in alterations of the LBs morphology. In conclusion, a level of lipid unsaturation and eosinophilic peroxidase as well as LBs distribution among cell population mainly accounted for the biochemistry of eosinophils upon inflammation.

Indexed as

BiomarkersCells, CulturedEosinophilsHumansInflammationBiomarkersCoherent anti-Stokes Raman scattering (CARS)EoL-1 cellsFluorescence microscopyPrimary isolated eosinophils (Eos)Spontaneous Raman spectroscopy

Identifiers

PMID34936035
PMCPMC8739296
OpenAlexW4200041373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.